BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer

Molecular and Cellular Biology

Volumn 24, Issue 13, 2004, Pages 5900-5913

  Razandi, Mahnaz ^a,b   Pedram, Ali ^a,b   Rosen, Eliot M ^d   Levin, Ellis R ^a,b,c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BRCA1 PROTEIN; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; SOMATOMEDIN C;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN MCF 7; ENZYME ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

BRCA1 PROTEIN; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; ESTRADIOL; HUMANS; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; RECEPTORS, ESTROGEN; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 2942726209     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.13.5900-5913.2004     Document Type: Article

References (54)

1. Baer, R., and T. Ludwig. 2002. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev. 12:86-91.
2. Casey, G. 1995. The BRCA1 and BRCA2 breast cancer genes. Curr. Opin. Oncol. 9:88-93.
3. Chen, Y., A. A. Farmer, C.-F. Chen, D. C. Jones, P.-L. Chen, and W.-H. Lee. 1996. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56:3168-3172.
4. Chu, Y., P. A. Solski, R. Khosravi-Far, C. J. Der, and K. Kelly. 1996. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271:6497-6501.
5. Couse, J. F., S. W. Curtis, T. F. Washburn, J. Lindzey, T. S. Golding, D. B. Lubahn, O. Smithies, and K. S. Korach. 1995. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 9:1441-1454.
6. Fan, S., J.-A. Wang, R. Yuan, Y. Ma, Q. Meng, M. R. Erdos, R. G. Pestell, F. Yuan, K. J. Auborn, I. D. Goldberg, and E. M. Rosen. 1999. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284:1354-1356.
7. Fan, S., Y. X. Ma, C. Wang, R. Q. Yuan, Q. Meng, J. A. Wang, M. Erdos, I. D. Goldberg, P. Webb, P. J. Kushner, R. G. Pestell, and E. M. Rosen. 2001. Role of direct interaction in BRCAI inhibition of estrogen receptor activity. Oncogene 20:77-87.
8. Filardo, E. J., J. A. Quinn, K. I. Bland, and A. R. Fracketton. 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, gpr30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14:1649-1660.
9. Fruman, D. A., R. E. Meyers, and L. C. Cantley. 1998. Phosphoinositide kinases. Annu. Rev. Biochem. 67:481-507.
10. Gowen, L. C., A. V. Avrutskaya, A. M. Latour, B. H. Koller, and S. A. Leadon. 1998. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281:1009-1012.
11. Harkin, D. P., J. M. Bean, D. Miklos, Y.-H. Song, V. B. Truong, C. Englert, F. C. Christians, L. W. Ellisen, S. Maheswaran, J. D. Oliner, and D. A. Haber. 1999. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97:575-586.
12. Kaufmann, K., and G. Thiel. 2002. Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J. Cell. Biochem. 85:381-391.
13. Kousteni, S., T. Bellido, L. I. Plotkin, C. A. O'Brien, D. L. Bodenner, L. Han, K. Han, G. B. DiGregorio, J. A. Katzenellenbogen, B. S. Katzenellenbogen, P. K. Roberson, R. S. Weinstein, R. L. Jilka, and S. C. Manolagas. 2001. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730.
14. Kumar, R., E.-A. Wang, A. Mazumdar, A. H. Talukder, M. Mandal, Z. Yang, R. Bagheri-Yarmand, A. Sahin, G. Hortobagyi, L. Adam, C. J. Barnes, and R. K. Vadlamudi. 2002. A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature 418:654-657.
15. Levin, E. R. 2003. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol. Endocrinol. 17:309-317.
16. Loman, N., O. Johannsson, P. O. Bendahl, A. Borg, M. Ferno, and H. Olsson. 1998. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83:310-319.
17. MacLachlan, T. K., R. Takimoto, and W. S. El-Deiry. 2002. BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol. Cell. Biol. 22:4280-4292.
18. Marino, M., F. Acconcia, F. Bresciani, A. Weisz, and A. Trentalance. 2002. Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol. Biol. Cell. 13:3720-3729.
19. Marks, J. R., G. Huper, J. P. Vaughn, P. L. Davis, J. Norris, D. P. McDonnell, R. W. Wiseman, P. A. Futreal, and J. D. Iglehart. 1997. BRCA1 expression is not directly responsive to estrogen. Oncogene 14:115-121.
20. Marquez, D. C., and R. J. Pietras. 2001. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 20:5420-5430.
21. Miki, Y., J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-72.
22. Moynahan, M. E., J. W. Chiu, B. H. Koller, and M. Jasin. 1999. Brca1 controls homology-directed DNA repair. Mol. Cell 4:511-518.
23. Murphy, L. O., S. Smith, R. H. Chen, D. C. Fingar, and J. Blenis. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell. Biol. 4:556-564.
24. Pedram, A., M. Razandi, M. Aitkenhead, C. C. W. Hughes, and E. R. Levin. 2002. Integration of the non-genomic and genomic actions of estrogen: membrane initiated signaling by steroid (MISS) to transcription and cell biology. J. Biol. Chem. 277:50768-50775.
25. Pedram, A., M. Razandi, and E. R. Levin. 2002. Deciphering VEGF signaling to vascular permeability: inhibition by atrial natriuretic peptide. J. Biol. Chem. 277:44385-44398.
26. Pedram, A., M. Razandi, R.-M. Hu, and E. R. Levin. 1998. Astrocyte progression through G1-S phase of the cell cycle depends upon multiple protein interactions. J. Biol. Chem. 273:13966-13972.
27. Pines, J., and T. Hunter. 1992. Cyclins A and B1 in the human cell cycle. Ciba Found. Symp. 170:187-196.
28. Prenzel, N., E. Zwick, M. Leserer, and A. Ullrich. 2000. Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification. Breast Cancer Res. 2:184-190.
29. Razandi, M., A. Pedram, and E. R. Levin. 2000. Estrogen signals to preservation of endothelial cell form and function. J. Biol. Chem. 275:38540-38546.
30. Razandi, M., G. Alton, A. Pedram, S. Ghonshani, P. Webb, and E. R. Levin. 2003. Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane. Mol. Cell. Biol. 23:1633-1646.
31. Razandi, M., P. Oh, A. Pedram, J. Schnitzer, and E. R. Levin. 2002. Estrogen receptors associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 16:100-115.
32. Razandi, M., A. Pedram, S. Parks, and E. R. Levin. 2003. Proximal events in ER signaling from the plasma membrane. J. Biol. Chem. 278:2701-2712.
33. Rebbeck, T. R., A. M. Levin, A. Eisen, C. Snyder, P. Watson, L. Cannon-Albright, C. Isaacs, O. Olopade, J. E. Garber, A. K. Godwin, M. B. Dal, S. A. Narod, S. L. Neuhausen, H. T. Lynch, and B. L. Weber. 1999. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J. Natl. Cancer Inst. 91:1475-1479.
34. Robbins, D. J., E. Zhen, H. Owaki, C. A. Vanderbilt, D. Ebert, T. D. Geppert, and M. H. Cobb. 1993. Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J. Biol. Chem. 268:5097-5106.
35. Santen, R. J., and G. R. Petroni. 1999. Relative versus attributable risk of breast cancer from estrogen replacement. J. Clin. Endocrinol. Metabol. 84:1875-1881.
36. Santen, R. J., R. X. Song, R. McPherson, R. Kumar, L. Adam, M. H. Jeng, and W. Yue. 2002. The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol. 80:239-256.
37. Scully, R., and D. M. Livingston. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408:429-432.
38. Shao, N., Y. L. Chai, E. Shyam, P. Reddy, and V. N. Rao. 1996. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13:1-7.
39. Singer, C. A., X. A. Figueroa-Masot, R. H. Batchelor, and D. M. Dorsa. 1999. The mitogen activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19:2455-2463.
40. Somasundaram, K., H. Zhang, Y.-X. Zeng, Y. Houvras, Y. Peng, H. Zhang, G. S. Wu, J. D. Licht, B. L. Weber, and W. S. El-Deiry. 1997. Arrest of the cell cycle by the tumor-suppressor BRCA1 requires the CDK-inhibitor p21waf1/CiP1. Nature 280:187-189.
41. Stoica, G. E., T. F. Franke, A. Wellstein, F. Czubayko, H. J. List, R. Reiter, E. Morgan, M. B. Martin, and A. Stoica. 2003. Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Mol. Endocrinol. 17:818-830.
42. Stratton, M. R., D. Ford, S. Neuhasen, S. Seal, R. Wooster, L. S. Friedman, M. C. King, V. Egilsson, P. Devilee, R. McManus, et al. 1994. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat. Genet. 7:103-107.
43. Stuart, N. S., J. Warwick, G. R. Blackledge, D. Spooner, C. Keen, A. R. Taylor, C. Tyrell, D. J. Webster, and H. Earl. 1996. A randomized phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer. Eur. J. Cancer 32:1888-1892.
44. Svegliati-Baroni, G., F. Ridolfi, A. Di Sario, A. Casini, L. Marucci, G. Gaggiotti, P. Orlandoni, G. Macarri, L. Perego, A. Benedetti, and F. Folli. 1999. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 29:1743-1751.
45. Tomlinson, G. E., T. T.-L. Chen, V. A. Stastny, A. K. Kirmani, M. A. Spillman, V. Tonk, J. L. Blum, N. R. Schneider, I. I. Wistuba, J. W. Shay, J. D. Minna, and A. F. Gazdar. 1998. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res. 58:3237-3242.
46. Venkitaraman, A. R. 2002. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171-182.
47. Watters, J. J., T. Y. Chun, Y. N. Kim, P. J. Bertics, and J. Gorski. 2000. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol. Endocrinol. 14:1872-1881.
48. White, R., and M. G. Parker. 1998. Molecular mechanisms of steroid hormone action. Endocr.-Rel. Cancer 5:1-14.
49. Xu, X., Z. Weaver, S. P. Linke, C. Li, J. Gotay, X.-W. Wang, C. C. Harris, T. Ried, and C.-X. Deng. 1999, Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3:389-395.
50. Yan, Y., J. P. Haas, M. Kim, M. K. Sgagias, and K. H. Cowan. 2002. BRCA1-induced apoptosis involves inactivation of ERK1/2 activities. J. Biol. Chem. 277:33422-33430.
51. Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021.
52. Zhang, X., and D. Yee. 2000. Tyrosine kinase signaling in breast cancer: insulin-like growth factors and their receptors in breast cancer. Breast Cancer Res. 2:170-175.
53. Zhang, Z., B. Maier, R. J. Santen, and R. X. Song. 2002. Membrane association of estrogen receptor alpha mediates estrogen effect on MAPK activation. Biochem. Biophys. Res. Commun. 294:926-933.
54. Zheng, L., L. A. Annab, C. A. Afshari, W.-H. Lee, and T. G. Boyer. 2001. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. USA 98:9587-9592.